University of Missouri School of Medicine MU Health School of Medicine
News Divider

MU Researchers Discover Protein's Ability To Inhibit HIV Release

TIM-family proteins also play role in Ebola and other viral infections

A family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, University of Missouri researchers have found.

“This is a surprising finding that provides new insights into our understanding of not only HIV infection, but also that of Ebola and other viruses,” said Shan-Lu Liu, MD, PhD, associate professor in the MU School of Medicine’s Department of Molecular Microbiology and Immunology.

Shan-Lu Liu, MD, PhD

The study was recently published in the Proceedings of the National Academy of Sciences. Liu, the corresponding author of the study, is also an investigator with the Christopher S. Bond Life Sciences Center at MU.

According to estimates from the Centers for Disease Control and Prevention, more than one million Americans currently are living with HIV infection. AIDS, which stands for acquired immunodeficiency syndrome, is a condition characterized by progressive failure of the immune system. It is caused by the human immunodeficiency virus type 1 (HIV-1).

When HIV-1 or any virus infects a cell, it replicates and spreads to other cells. One type of cellular protein — T cell immunoglobulin and mucin domain, or TIM-1 — has previously been shown to promote entry of some highly pathogenic viruses into host cells. Now, the MU researchers have found that the same protein possesses a unique ability to block the release of HIV-1 and Ebola virus.

“This study shows that TIM proteins keep viral particles from being released by the infected cell and instead keep them tethered to the cell surface,” said Gordon Freeman, PhD, an associate professor of medicine with Harvard Medical School’s Dana-Farber Cancer Institute, who was not affiliated with the study. “This is true for several important enveloped viruses including HIV and Ebola. We may be able to use this insight to slow the production of these viruses.”

Minghua Li

Under the supervision of Liu, Minghua Li, a graduate student in the MU Pathobiology Area Program, performed a series of experiments that revealed the protein’s ability to inhibit HIV-1 release, resulting in diminished viral production and replication.

HIV-1 attacks cells that are vital to the body’s immune system, such as T cells. These white blood cells play an important role in the body’s response to infection, but HIV-1 disrupts the cells’ ability to fight back against infection. When the virus enters a host cell, it infects the cell and replicates, producing viral particles that spread to and infect other cells. The researchers found that as the viral particles attempt to bud from, or leave, the infected cell, the TIM-family proteins located on the surface of the cell can attach to lipids on the surface of the viral particle.

These lipids – known as phosphatidylserine (PS) — are normally present on the inner side of the cellular membrane but can be exposed to the outer side upon viral infection. When the TIM-family proteins come in contact with PS, the viral particle becomes attached to the host cell, keeping the particle from being released from the cell. Because TIM-family proteins and PS are present on the surface of the cell and the viral particle, the viral particles get stuck to one another, forming a network of viral particles that accumulate on the surface of the host cell, rather than being released to infect other cells.

By using molecular, biochemical and electron microscopic approaches, the researchers observed the TIM and PS interactions in human cells. The next step is for the researchers to study the biological significance of TIM-family proteins in animals and patients and to determine the fate of the infected cell once it accumulates a buildup of viral particles.

“We are not at the point to draw a conclusion as to whether this is a positive or a negative factor,” Liu said. “However, this discovery furthers our ultimate goal of understanding the biology of TIM-family proteins and potentially developing applications for future antivirus therapies.”

The study, “TIM-Family Proteins Inhibit HIV-1 Release,” is supported in part by the National Institutes of Health and the University of Missouri. In addition to Liu and Li, researchers include Eric Freed, PhD, senior investigator with the National Cancer Institute (NCI) HIV Drug Resistance Program; Sherimay Ablan, biologist with the NCI HIV Drug Resistance Program; Marc Johnson, PhD, associate professor in the MU Department of Molecular Microbiology and Immunology; Chunhui Miao and Matthew Fuller, graduate students in the MU Department of Molecular Microbiology and Immunology; Yi-Min Zheng, MD, MS, senior research specialist with the Christopher S. Bond Life Sciences Center at MU; Paul Rennert, PhD, founder and principal of SugarCone Biotech LLC in Holliston, Massachusetts; and Wendy Maury, PhD, professor of microbiology at the University of Iowa.


MU Health Magazine


News and Events

Rural Track Pipeline Program MU School of Medicine Celebrates 20th Anniversary of Rural Track Pipeline Program
Aim is to address shortage of physicians in rural areas

Gerald Meininger, PhD Professor Recognized as International Leader in Microcirculation Research
Vascular health expert recently received prestigious Kitanomaru Award in Japan

Health Sciences Research Day MU Health Students, Faculty Receive Awards at Annual Health Sciences Research Day
Event features projects from student and physician researchers

Jane McElroy, PhD Resilience-based Interventions Could Curb Depression in LGBT Youths
Researchers suggest strategies to improve mental health of young people

Erika Ringdahl, MD MU Awarded $1.1 Million to Enhance Role of Primary Care Physicians
Program will train primary care doctors to create patient-centered medical homes

Quinn Johnson Johnson Named MU
Anesthesiology Chair

Clinician educator joined University of Missouri in 2010

Vogel Taking Cholesterol Medication Before Aneurysm Repair Improves Outcomes
Patients taking statins before endovascular aortic aneurysm surgery more likely to survive

Thakkar New Finding Helps Explain Why Many Alcohol Drinkers Also Are Smokers
Knowledge may help curb alcohol and nicotine addiction

Dongsheng Duan, PhD Gene Therapy Treats All Muscles in the Body in Muscular Dystrophy Dogs
Human clinical trials are next step, MU researchers say

Peter Konig, MD Test Catches Asthma in Children Before Symptoms Appear
Researchers find common pulmonary function test can help with early diagnosis

Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
(573) 882-7299

Jeff Hoelscher
(573) 884-1608

Derek Thompson
(573) 882-3323

Diamond Dixon
(573) 884-7541

Justin Kelley (Photographer)
(573) 882-5786
Pager (573) 397-9289

Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Laura Gerding, APR
(573) 882-9193

Velvet Hasner
(573) 884-1115

Justin Willett
(573) 884-7740

Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: August 26, 2014 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.